If the government takes a progressive view and the industry co-operates for arriving at a pricing mechanism, it will be a win-win for all, Raju Barwale, managing director of Mahyco (Maharashtra Hybrid Seeds Company Ltd), tells Dilip Kumar Jha.
Data on clinical trials of genetically-modified brinjal have been made public by the Genetic Engineering Approval Committee of the environment ministry.
Even though the supporters of GM foods have ample arguments to counter the robust opposition to Bt brinjal, Jairam Ramesh's current tour shows that the seed companies who are eyeing the Indian market may not find the going very easy.
Maharashtra Hybrid Seeds Company Ltd (Mahyco), the seed partner of multinational agro-biotech major Monsanto Corporation, has moved the Delhi High Court against a Central Information Commission order seeking details of the safety test data generated during clinical trials of its genetically modified (GM) brinjal, the first GM edible crop to be introduced in India.